Sfoglia per Autore  

Opzioni
Mostrati risultati da 61 a 80 di 105
Titolo Data di pubblicazione Autori File
Computer simulation of polypropylene/organoclay nanocomposites: characterization of atomic scale structure and prediction of binding energy 1-gen-2004 TOTH, RADOVANFERRONE, MARCOFERMEGLIA, MAURIZIOPRICL, SABRINA +
Diffusion of proteins in nanochannels. A many-scale simulation approach 1-gen-2005 FERRONE, MARCOFERMEGLIA, MAURIZIOPRICL, SABRINA +
Non-nucleoside anti-Flaviviridae agents from different molecular classes: a jointed experimental/modeling effort 1-gen-2005 FERRONE, MARCOPRICL, SABRINA +
Take a walk on the nano side: structural and energetical analysis of ATP-binding pocket mutations of the cardiac beta-myosin heavy chain implicated in familial hypertrophic cardiomyopathy 1-gen-2005 FERRONE, MARCOPANENI, Maria SilviaFERMEGLIA, MAURIZIOPRICL, SABRINA +
T670X kit mutations in gastrointestinal stromal tumors: making sense of missense 1-gen-2005 PRICL, SABRINAFERRONE, MARCOPANENI, Maria SilviaFERMEGLIA, MAURIZIO +
Three-dimensional Pharmacophore Modeling of Hindered Nucleoside Analogs (HNAs) as Inhibitors of the Hepatitis C virus NS5B Polymerase 1-gen-2005 FERRONE, MARCOPRICL, SABRINAFERMEGLIA, MAURIZIOPANENI, Maria Silvia +
Novel Aryl Diketo Acids (ADKs) as Inhibitors of Hepatitis C Virus NS5b RNA-Dependent RNA-Polymerase: Better Understanding Through Molecular Modeling 1-gen-2005 PRICL, SABRINAFERMEGLIA, MAURIZIOFERRONE, MARCOPANENI, Maria Silvia +
Upgrading block co-polymers from post industrial rejects: a multiscale simulation approach 1-gen-2005 FERMEGLIA, MAURIZIOFERRONE, MARCOPANENI, Maria SilviaPRICL, SABRINA +
Simulation insight on the structure and energetics of biocompatible polymer nanocomposite systems 1-gen-2005 TOTH, RADOVANFERRONE, MARCOFERMEGLIA, MAURIZIOPRICL, SABRINA +
Where are we in HIV research? A novel, computer-based strategy predicting resistance to HIV-1 NNRTIs 1-gen-2005 PANENI, Maria SilviaFERRONE, MARCOFERMEGLIA, MAURIZIOPRICL, SABRINA +
TT315I mutated bcr-abl in chronic myeloid leukemia and imatinib: insights from a computational study 1-gen-2005 FERMEGLIA, MAURIZIOFERRONE, MARCOPRICL, SABRINA +
Changes and challenges: GIST, mutated C-KIT and imatinib resistance 1-gen-2005 PRICL, SABRINAFERRONE, MARCOPANENI, Maria SilviaFERMEGLIA, MAURIZIO +
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 1-gen-2005 MAMOLO, MARIA GRAZIAZAMPIERI, DANIELEVIO, LUCIANOFERMEGLIA, MAURIZIOFERRONE, MARCOPRICL, SABRINABANFI, ELENA +
Fighting cancer at the nanoscale: computational structural biology and the Bcr-Abl/Imatinib paradigm 1-gen-2005 FERRONE, MARCOPANENI, Maria SilviaFERMEGLIA, MAURIZIOPRICL, SABRINA +
Can computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm 1-gen-2005 PRICL, SABRINAFERRONE, MARCOPANENI, Maria SilviaFERMEGLIA, MAURIZIO +
Nano-scaled inorganic/biopolymer composites: Molecular modeling vistas 1-gen-2005 TOTH, RADOVANFERRONE, MARCOFERMEGLIA, MAURIZIOPRICL, SABRINA +
A simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors 1-gen-2005 FERMEGLIA, MAURIZIOFERRONE, MARCOPANENI, Maria SilviaPRICL, SABRINA +
Of life and Death: Chronic Myeloid Leukemia and the Bcr-Abl/Imatinib Paradigm 1-gen-2006 FERRONE, MARCOFERMEGLIA, MAURIZIOPANENI, Maria SilviaPRICL, SABRINA +
Angels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer. 1-gen-2006 PRICL, SABRINAFERRONE, MARCOPANENI, Maria SilviaFERMEGLIA, MAURIZIO +
Chasing the evaders. Design, synthesis, activity and molecular modelling of a new small molecule with activity against drug-resistant HIV-1-mutants 1-gen-2006 PRICL, SABRINAFERRONE, MARCOPOSOCCO, PAOLAFERMEGLIA, MAURIZIO +
Mostrati risultati da 61 a 80 di 105
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile